About Intersect ENT
Intersect ENT is a company based in Menlo Park (United States) founded in 2003 was acquired by Medtronic in August 2021.. Intersect ENT has raised $76.53 million across 4 funding rounds from investors including Medtronic, Kleiner Perkins and Norwest Venture Partners. The company has 371 employees as of December 31, 2022. Intersect ENT has completed 1 acquisition, including Fiagon. Intersect ENT operates in a competitive market with competitors including Tivic Health, Acclarent, Entellus Medical, MyPurMist and Dalent Medical, among others.
- Headquarter Menlo Park, United States
- Employees 371 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
362 people
Leadership Team
153 people
Sales and Marketing
123 people
Senior Team
61 people
Product Management Team
61 people
Finance and Accounting
52 people
Human Resources and Administration
40 people
Principal Team
28 people
Unlock access to complete
Funding Insights of Intersect ENT
Intersect ENT has successfully raised a total of $76.53M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $65 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $65.0M
-
First Round
First Round
(08 Nov 2010)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Post-IPO - Intersect ENT | Valuation |
investors |
|
| Mar, 2013 | Amount | Series D - Intersect ENT | Valuation |
investors |
|
| Sep, 2011 | Amount | Series C - Intersect ENT | Valuation | Medtronic , USVP |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Intersect ENT
Intersect ENT has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Kleiner Perkins and Norwest Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location | |
|
VC firm that focuses on early stage investments in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Intersect ENT
Intersect ENT has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fiagon. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical navigation systems for surgical applications to healthcare providers
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Intersect ENT
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intersect Ent Comparisons
Competitors of Intersect ENT
Intersect ENT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tivic Health, Acclarent, Entellus Medical, MyPurMist and Dalent Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Bioelectronic devices for sinusitis pain relief are developed.
|
|
| domain | founded_year | HQ Location |
Balloon-based sinuplasty technologies are developed for ENT surgeons.
|
|
| domain | founded_year | HQ Location |
Minimally invasive products for chronic sinusitis treatment are developed.
|
|
| domain | founded_year | HQ Location |
Medical humidification devices are developed with patented CFV technology.
|
|
| domain | founded_year | HQ Location |
Balloon-based sinus dilation devices are developed for sinusitis treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intersect Ent
Frequently Asked Questions about Intersect ENT
When was Intersect ENT founded?
Intersect ENT was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Where is Intersect ENT located?
Intersect ENT is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Intersect ENT a funded company?
Intersect ENT is a funded company, having raised a total of $76.53M across 4 funding rounds to date. The company's 1st funding round was a Series C of $31.02M, raised on Nov 08, 2010.
How many employees does Intersect ENT have?
As of Dec 31, 2022, the latest employee count at Intersect ENT is 371.
What does Intersect ENT do?
Developer of a drug-releasing implant to treat sinusitis. The company has developed drug-releasing implants called CE marked and FDA-approved dissolvable implants for the treatment of chronic sinusitis called Propel, Propel Mini and PROPEL Contour. The devices consist of a spring-like implant that expands to open the ethmoid sinus and dissolves to deliver corticosteroids with anti-inflammatory properties to the sinus lining. The company claims that the device is clinically proven to prevent obstruction of the ethmoid sinus following surgery.
Who are the top competitors of Intersect ENT?
Intersect ENT's top competitors include Tivic Health, Entellus Medical and MyPurMist.
How many acquisitions has Intersect ENT made?
Intersect ENT has made 1 acquisition, including Fiagon.
Who are Intersect ENT's investors?
Intersect ENT has 6 investors. Key investors include Medtronic, Kleiner Perkins, Norwest Venture Partners, PTV Healthcare Capital, and Deerfield.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.